KKR closed its $5.89 billion acquisition of Integer Holdings Corporation in August, the largest private equity transaction of the month and the sole healthcare deal above $3 billion as global PE dealmaking contracted 40% month-over-month. The medical device manufacturer, which produces components for cardiac rhythm management and neuromodulation systems, now operates as a KKR portfolio company after sixteen months of regulatory clearance and commercial diligence.
August PE volume dropped to $47 billion across 183 disclosed transactions, down from $78 billion in July, according to data aggregated from Preqin and Pitchbook. Healthcare represented 31% of that total—$14.6 billion across 22 deals—with Integer accounting for two-fifths of the sector's monthly volume. The closure timing coincides with Federal Reserve signaling on September rate trajectory, which has frozen buyout financing for transactions requiring more than 60% leverage. KKR structured Integer with 52% debt-to-enterprise-value, below the 58% median for healthcare PE in 2024, and committed $2.8 billion in equity from its Americas Fund XIII and Next Generation Technology Growth Fund II.
The acquisition matters because it demonstrates continued appetite for scaled healthcare infrastructure plays even as venture-stage biotech and early-commercial therapeutics funding has fallen 67% year-over-year. Integer generated $1.46 billion in trailing revenue with 22% EBITDA margins, derived from long-cycle contracts with Medtronic, Abbott, and Boston Scientific. KKR's thesis centers on procedural volume recovery in electrophysiology and the $4.2 billion addressable market for next-generation leadless pacemaker components, where Integer holds 190 active patents. The firm plans to consolidate Integer's five manufacturing facilities into three higher-automation sites by Q2 2026, targeting 400 basis points of margin expansion.
The deal also marks a structural shift in PE sector composition. Technology buyouts, which represented 38% of 2023 deal volume, fell to 19% in August as software multiples compressed and growth assumptions reset. Meanwhile, healthcare's share rose from 23% to 31%, driven by demographic certainty and regulatory clarity post-IRA. Three other healthcare PE closures occurred in August: Bain's $1.1 billion take-private of Amneal Pharmaceuticals, Carlyle's $890 million add-on of imaging provider Akumin to US Radiology, and CD&R's $640 million acquisition of specialty pharmacy ServiceRx. Each carried debt ratios under 5.5x EBITDA, reflecting lender caution and sponsor discipline.
Operators should monitor KKR's Q4 2024 investor letter for early Integer performance metrics, particularly organic revenue growth in the cardiac rhythm management segment, which has posted declining volumes in seven of the past nine quarters across the broader market. The firm's planned facility consolidation will surface in CapEx disclosures by February 2025. Separately, three additional healthcare PE processes are expected to close before year-end: TPG's $2.3 billion acquisition of Covetrus veterinary platform, Advent's $1.8 billion take-private of RadNet imaging centers, and Welsh Carson's $950 million purchase of behavioral health operator Acadia's non-core assets. Combined, these would push 2024 healthcare PE volume above $62 billion, the highest annual total since 2021.
Integer's commercial agreements with its top three customers extend through 2028 with automatic renewal clauses and minimum purchase commitments totaling $1.9 billion. KKR underwrote the deal assuming 4.2% compound annual growth and 24% exit EBITDA margins. The firm has not disclosed its target hold period, but comparable healthcare technology platform exits since 2019 have averaged 5.8 years from acquisition to sale or IPO.
The takeaway
Healthcare PE claimed 31% of August volume despite 40% sector-wide contraction; Integer's $5.89B closure signals sustained appetite for scaled device infrastructure.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori Press · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.